• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Ekso Bionics Holdings Inc (EKSO)

Common Shares
Sell: $3.31|Buy: $3.48|Change: 0.10 (3.11%)

Open 

$3.22

Previous close 

$3.22

Trade high 

$3.45

Volume 

60,866

Year high 

$22.95

Year low 

$2.73

Dividend yield 

–

Market capitalisation 

$7.86 mn

P/E ratio 

–

ISIN 

US2826444000

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Share price

Performance 16/07/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Ekso Bionics Holdings Inc+ 3.11
More...

Company profile

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

Sector 

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.